跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42 条关于
“H2L2”
全部
42
临床试验
20
药物
6
机构
0
资讯
16
去年
Nona Biosciences Expands Reach with Strategic Partnerships in Animal Health and Breast Cancer Therapeutics
4个月前
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance AI-Driven Drug Discovery Platform
10个月前
Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Biologics Discovery
10个月前
Pfizer Partners with Nona Biosciences for Heavy Chain-Only Antibody Discovery Platform
9个月前
Harbour BioMed Expands AstraZeneca Partnership for Next-Generation Oncology Therapeutics
9个月前
Harbour BioMed Partners with Bristol Myers Squibb in $1.1 Billion Multi-Specific Antibody Deal
去年
Harbour BioMed to Present Phase II Data on Novel Anti-CTLA-4 Antibody Combination for Treatment-Resistant Colorectal Cancer at ESMO 2025
去年
China Patent Office Upholds Harbour BioMed's Heavy Chain Antibody Patent in Legal Victory Over Biocytogen
去年
Harbour BioMed Appoints Yajie Li as Chief Medical Officer to Advance Antibody Therapeutics Pipeline
10个月前
Nona Biosciences Expands CAR-T Partnership with Umoja Biopharma to Develop In Vivo Cell Therapies
第 1 页,共 2 页
上一页
下一页